COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 3093: Articles 30921-30930  | Next

Role of temperature and humidity in the modulation of the doubling time of COVID-19 cases
Oliveiros, B., Caramelo, L., Ferreira, N. C., Caramelo, F.
10.1101/2020.03.05.20031872 — Posted: 2020-03-08 Discussion: Onsite
The prevalence and influencing factors for anxiety in medical workers fighting COVID-19 in China: A cross-sectional survey
Liu, C., Yang, Y.-z., Zhang, X. M., Xu, X., Dou, Q.-L., Zhang, W.-W.
10.1101/2020.03.05.20032003 — Posted: 2020-03-08
Evaluating the secondary transmission pattern and epidemic prediction of the COVID-19 in metropolitan areas of China
Hong, N., He, J., Ma, Y., Jiang, H., Han, L., Su, L., Zhu, W., Long, Y.
10.1101/2020.03.06.20032177 — Posted: 2020-03-08
Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole
Xia, W., Liao, J., Li, C., Li, Y., Qian, X., Sun, X., Xu, H., Mahai, G., Zhao, X., Shi, L., Liu, J., Yu, L., Wang, M., Wang, Q., Namat, A., Li, Y., Qu, J., Liu, Q., Lin, X., Cao, S., Huan, S., Xiao, J., Ruan, F., Wang, H., Xu, Q., Ding, X., Fang, X., Qiu, F., Ma, J., Zhang, Y., Wang, A., Xing, Y., Xu, S.
10.1101/2020.03.06.20031955 — Posted: 2020-03-08
COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients
Song, C.-Y., Xu, J., He, J.-Q., Lu, Y.-Q.
10.1101/2020.03.05.20031906 — Posted: 2020-03-08 Discussion: Onsite | Offsite
Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19
Moore, S. C., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S. T., Carter, D., Bewley, K., Zhao, Q., Sun, Y., Hartley, C., Zhou, E.-m., Solomon, T., Beadsworth, M. B. J., Cruise, J., Bogaert, D., Crook, D. W. T., Matthews, D. A., Davidson, A. D., Mahmood, Z., Aljabr, W., Druce, J., Vipond, R. T., Ng, L., Renia, L., Openshaw, P., Baillie, J. K., Carroll, M. W., Semple, C., Turtle, L., Hiscox, J. A.
10.1101/2020.03.05.20032011 — Posted: 2020-03-08 Discussion: Offsite
CORONAVIRUS IN PREGNANCY AND DELIVERY: RAPID REVIEW AND EXPERT CONSENSUS
Mullins, E., Evans, D., Viner, R., O'Brien, P., Morris, E.
10.1101/2020.03.06.20032144 — Posted: 2020-03-08
Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design
Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Hilgenfeld, R., Drag, M.
10.1101/2020.03.07.981928 — Posted: 2020-03-08 Discussion: Onsite
AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2
Tang, B., He, F., Liu, D., Fang, M., Wu, Z., Xu, D.
10.1101/2020.03.03.972133 — Posted: 2020-03-08
Appealing for Efficient, Well Organized Clinical Trials on COVID-19
Zhao, Y., Wei, Y., Shen, S., Zhang, M., Chen, F.
10.1101/2020.03.05.20031476 — Posted: 2020-03-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).